Latest Insider Transactions at Quidel Ortho Corp (QDEL)
This section provides a real-time view of insider transactions for Quidel Ortho Corp (QDEL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of QuidelOrtho Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of QuidelOrtho Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 23
2023
|
Douglas C Bryant President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,527
-1.39%
|
$662,376
$88.71 P/Share
|
|
Feb 23
2023
|
Douglas C Bryant President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,180
+2.72%
|
-
|
|
Feb 17
2023
|
Kenneth F Buechler |
SELL
Open market or private sale
|
Direct |
8,081
-10.31%
|
$727,290
$90.26 P/Share
|
|
Feb 17
2023
|
Kenneth F Buechler |
BUY
Exercise of conversion of derivative security
|
Direct |
8,081
+9.35%
|
$185,863
$23.7 P/Share
|
|
Feb 11
2023
|
Werner Kroll SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
1,705
-2.94%
|
$146,630
$86.5 P/Share
|
|
Feb 11
2023
|
Werner Kroll SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
3,566
+5.7%
|
-
|
|
Feb 11
2023
|
Douglas C Bryant President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,540
-0.43%
|
$390,440
$86.5 P/Share
|
|
Feb 11
2023
|
Douglas C Bryant President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,501
+0.89%
|
-
|
|
Feb 11
2023
|
Robert Joseph Bujarski EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,815
-2.45%
|
$156,090
$86.5 P/Share
|
|
Feb 11
2023
|
Robert Joseph Bujarski EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
3,573
+4.55%
|
-
|
|
Feb 04
2023
|
Werner Kroll SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
4,064
-7.43%
|
$361,696
$89.7 P/Share
|
|
Feb 04
2023
|
Werner Kroll SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
8,193
+13.03%
|
-
|
|
Feb 04
2023
|
Douglas C Bryant President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,282
-1.75%
|
$826,098
$89.7 P/Share
|
|
Feb 04
2023
|
Douglas C Bryant President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
18,720
+3.4%
|
-
|
|
Feb 04
2023
|
Robert Joseph Bujarski EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,905
-5.25%
|
$169,545
$89.7 P/Share
|
|
Feb 04
2023
|
Robert Joseph Bujarski EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
3,623
+9.08%
|
-
|
|
Feb 03
2023
|
Douglas C Bryant President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,882
-0.37%
|
$167,498
$89.7 P/Share
|
|
Feb 03
2023
|
Douglas C Bryant President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,795
+0.73%
|
-
|
|
Feb 03
2023
|
Robert Joseph Bujarski EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
873
-2.61%
|
$77,697
$89.7 P/Share
|
|
Feb 03
2023
|
Robert Joseph Bujarski EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
1,660
+4.72%
|
-
|
|
Feb 01
2023
|
Douglas C Bryant President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
553
-0.11%
|
$48,664
$88.51 P/Share
|
|
Feb 01
2023
|
Douglas C Bryant President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,115
+0.22%
|
-
|
|
Feb 01
2023
|
Robert Joseph Bujarski EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
463
-1.43%
|
$40,744
$88.51 P/Share
|
|
Feb 01
2023
|
Robert Joseph Bujarski EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
879
+2.65%
|
-
|
|
Feb 01
2023
|
Michelle A. Hodges SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
162
-3.63%
|
$14,256
$88.51 P/Share
|
|
Feb 01
2023
|
Michelle A. Hodges SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
473
+9.58%
|
-
|
|
Feb 01
2023
|
Werner Kroll SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
651
-2.84%
|
$57,288
$88.51 P/Share
|
|
Feb 01
2023
|
Werner Kroll SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
1,312
+5.42%
|
-
|
|
Jan 31
2023
|
Douglas C Bryant President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,406
-0.66%
|
$289,510
$85.61 P/Share
|
|
Jan 31
2023
|
Douglas C Bryant President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,760
+1.3%
|
-
|
|
Jan 31
2023
|
Robert Joseph Bujarski EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,771
-5.33%
|
$150,535
$85.61 P/Share
|
|
Jan 31
2023
|
Robert Joseph Bujarski EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
3,219
+8.84%
|
-
|
|
Jan 31
2023
|
Michelle A. Hodges SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
643
-13.88%
|
$54,655
$85.61 P/Share
|
|
Jan 31
2023
|
Michelle A. Hodges SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,609
+25.78%
|
-
|
|
Jan 31
2023
|
Werner Kroll SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
1,840
-7.87%
|
$156,400
$85.61 P/Share
|
|
Jan 31
2023
|
Werner Kroll SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
3,547
+13.17%
|
-
|
|
Dec 31
2022
|
Evelyn S Dilsaver |
BUY
Grant, award, or other acquisition
|
Direct |
69
+12.55%
|
-
|
|
Dec 01
2022
|
Michelle A. Hodges SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
119
-3.79%
|
$11,067
$93.65 P/Share
|
|
Dec 01
2022
|
Michelle A. Hodges SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
238
+7.04%
|
-
|
|
Nov 18
2022
|
Robert Joseph Bujarski EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
544
-1.78%
|
$47,872
$88.4 P/Share
|
|
Nov 18
2022
|
Robert Joseph Bujarski EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
1,033
+3.27%
|
-
|
|
Nov 08
2022
|
Michelle A. Hodges SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,969
-40.4%
|
$171,303
$87.69 P/Share
|
|
Nov 08
2022
|
Michelle A. Hodges SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
3,970
+44.89%
|
-
|
|
Oct 15
2022
|
Michelle A. Hodges SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
193
-17.59%
|
$14,668
$76.29 P/Share
|
|
Oct 15
2022
|
Michelle A. Hodges SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
389
+26.18%
|
-
|
|
Oct 15
2022
|
Robert Joseph Bujarski EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
205
-0.69%
|
$15,580
$76.29 P/Share
|
|
Oct 15
2022
|
Robert Joseph Bujarski EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
389
+1.29%
|
-
|
|
Sep 30
2022
|
Evelyn S Dilsaver |
BUY
Grant, award, or other acquisition
|
Direct |
69
+14.35%
|
-
|
|
Sep 14
2022
|
Robert Joseph Bujarski EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
165
-0.56%
|
$13,695
$83.25 P/Share
|
|
Sep 14
2022
|
Robert Joseph Bujarski EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
313
+1.05%
|
-
|